Mission Bio Announces Biomarker Analysis Results in Myeloproliferative Neoplasms to be Presented at ASH 2025

Key claim: Mission Bio’s Tapestri single-cell multi-omics platform was used by Incyte to generate exploratory biomarker analysis data in MPNs, to be presented at ASH 2025.

Abstract

Mission Bio announced its Tapestri Platform and custom assay development supported initial exploratory biomarker analysis data for presentation by Incyte at ASH 2025 conference in Orlando, Florida, demonstrating Tapestri Platform’s ability to accelerate understanding of MPN disease biology at the single-cell level.

Why this matters

Pending synthesis.

Source

Link